Éric Jourdan

5.1k citations

54 papers · 2.1k indexed · h-index 18

Impact in

Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Genetics top 2%
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 44
- Acute Myeloid Leukemia Research 21
- Multiple Myeloma Research and Treatments 17
- Chronic Myeloid Leukemia Treatments 13
- Hematopoietic Stem Cell Transplantation 6
Genetics 18
- Chronic Lymphocytic Leukemia Research 11
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5

Co-authors: Bernard Klein Jérôme Moreaux Éric Legouffe Thierry Rème Karin Tarte John De Vos Jean‐François Rossi Philippe Quittet
Journals: Blood (23 papers)Haematologica (3 papers)Journal of Clinical Oncology (3 papers)British Journal of Haematology (2 papers)Human Gene Therapy (1 paper)
Partner nations: France Germany United States

In The Last Decade

Éric Jourdan

52 papers receiving 2.0k citations

Peers

Countries citing papers authored by Éric Jourdan

Since Specialization

Citations

This map shows the geographic impact of Éric Jourdan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Jourdan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Jourdan more than expected).

Fields of papers citing papers by Éric Jourdan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Jourdan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Jourdan. The network helps show where Éric Jourdan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Éric Jourdan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Éric Jourdan Line = papers co-authored together Éric Jourdan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discontinuation of tyrosine kinase inhibitor in chronic myeloid leukemia: a retrospective cohort in east occitania Annals of Hematology ·J. Hueber, Émile Pierret, Philippe Quittet, Елена Валериевна Манджиева, Flávia Gonçalves do Nascimento, Liyanage Ja, Weaam Abo Shdeed, Ayman Saad, Éric Jourdan, Yating Liu	2022	1
2	SNP-array lesions in core binding factor acute myeloid leukemia Oncotarget ·Nicolas Duployez, Marcia Choi, Christophe Roumier, Nicolas Boissel, Arnaud Petit, Sandrine Geffroy, Nathalie Hélevaut, Karine Celli‐Lebras, Christine Terré, Odile Fenneteau, Wendy Cuccuini, Isabelle Luquet, Hélène Lapillonne, Catherine Lacombe, Pascale Cornillet, Norbert Ifrah, Hervé Dombret, Guy Leverger, Éric Jourdan, Claude Preudhomme	2018	10
3	Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial Haematologica ·Christophe Willekens, Odile Blanchet, Aline Renneville, Pascale Cornillet‐Lefèbvre, Cécile Pautas, Romain Guièze, Norbert Ifrah, Hervé Dombret, Éric Jourdan, Claude Preudhomme, Nicolas Boissel, (unknown)	2015	87
4	A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure Leukemia Research ·Sylvain Thépot, Simone Boehrer, Weiyan Chen, Thomas Prébet, Odile Beyne‐Rauzy, Eric Wattel, Jacques Delaunay, Emmanuel Raffoux, Mathilde Hunault, Éric Jourdan, Fatiha Chermat, Marie Sébert, Guido Kroemer, Pierre Fenaux, Lionel Adès	2014	13
5	A multicenter phase II study of single-agent enzastaurin in previously treated multiple myeloma Leukemia & lymphoma ·Éric Jourdan, Véronique Leblond, Hervé Maisonneuve, Karim A. Benhadji, Anwar M. Hossain, Tuan S. Nguyen, James E. Wooldridge, Philippe Moreau	2013	15
6	Induction-related cost of patients with acute myeloid leukaemia in France International Journal of Clinical Pharmacy ·Virginie Nerich, Bruno Lioure, Scott Carter, Christian Récher, Arnaud Pigneux, Brigitte Witz, Martine Escoffre‐Barbe, Marie‐Pierre Moles, Éric Jourdan, J Cahn, Marie-Christine Woronoff-Lemsi	2011	17
7	Addition of Lomustine to Idarubicin and Cytarabine Improves the Outcome of Elderly Patients With De Novo Acute Myeloid Leukemia: A Report From the GOELAMS Journal of Clinical Oncology ·Arnaud Pigneux, Jean‐Luc Harousseau, Francis Witz, Andrew Kowalski, Marie C. Béné, Isabelle Luquet, Mathilde Hunault, Christian Récher, Bruno Lioure, Chantal Himberlin, Martine Escoffre‐Barbe, Christian Berthou, Séverine Lissandre, Nathalie Fegueux, Jean‐Yves Cahn, Éric Jourdan, François Dreyfus, Josy Reiffers, Nöel Milpied, Norbert Ifrah	2010	26
8	Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma Haematologica ·Nicola Gökbuget, Sandro Angelo Parrotta, Renato Bassan, Hans Guenter Derigs, Hervé Dombret, Tales Augusto Carvalho De Barros, Jesús María Hernández‐Rivas, F. Huguet, Tamara Intermesoli, Éric Jourdan, Christian Junghanß, Lothar Leimer, L F Gisclard, Albrecht Reichle, Josep‐María Ribera, Mathias Schmid, Hubert Serve, 山崎しのぶ, Reingard Stuhlmann, Maureece Day	2010	44
9	Association of Familial Pernicious Anaemia and Hereditary Haemochromatosis Acta Haematologica ·Mohammadi Najaf Abadi Hossain, Laurent Henry, Christophe Delfour, Anne Arnaud, Sophie Brun, Éric Mercier, Éric Jourdan, Serge Carillo, 유육례, Marie-Paule Meryem Benmostapha-Vannier, Pierre Blanc, Thierry Lavabre‐Bertrand	2008	3
10	Absolute Lymphocyte Count at 1st Remission Is Prognostic Factor for Disease Free and Overall Survival for Acute Myeloid Leukemia Under 60: Analysis of AML1 GOELAMS Trial Blood ·Bruno Lioure, Christian Récher, Patrice Chevallier, Arnaud Pigneux, Francis Witz, Norbert Vey, Nathalie Fegueux, Claude‐Eric Bulabois, Sylvie Daliphard, Fabrice Larosa, Martine Escoffre‐Barbe, Éric Jourdan, Olivier Tournilhac, Martine Delain, Denis Caillot, Mario Ojeda‐Uribe, Edouard Randriamalala, Roselyne Delépine, François Dreyfus, Norbert Ifrah	2008	1
11	Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results Haematologica ·Arnaud Pigneux, Mark Neubauer, Éric Jourdan, Norbert Vey, Nicole Dastugue, F. Huguet, 巣黒慎太郎, Ibeth Patricia, Norbert Ifrah, Josy Reiffers	2007	26
12	CD200 is a new prognostic factor in multiple myeloma Blood ·Jérôme Moreaux, Dirk Hose, Thierry Rème, Éric Jourdan, Michael Hundemer, Éric Legouffe, Pierre Moine, Philippe Bourin, M Moos, Jill Corre, Th. Möhler, John De Vos, Jean François Rossi, Hartmut Goldschmidt, Bernard Klein	2006	191
13	Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells Oncogene ·Karène Mahtouk, Dirk Hose, Thierry Rème, John De Vos, Michel Jourdan, Jérôme Moreaux, Geneviève Fiol, Marc S. Raab, Éric Jourdan, Aakansh Garg, Marion Moos, Hartmut Goldschmidt, Marion Baudard, Jean François Rossi, Friedrich W. Cremer, Bernard Klein	2005	80
14	Oneversustwo high‐dose cytarabine‐based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remission British Journal of Haematology ·Éric Jourdan, Françoise Rigal‐Huguet, Gérald Marit, Norbert Vey, Nicole Dastugue, Nathalie Fegueux, Lysiane Molina, 優次丹野, Laurence Legros, Sevınç Şahbaz, Susan Styer, Frédéric Bauduer, Dominique Bordessoule, Michel Attal, Didier Blaise, Arnaud Pigneux, (unknown)	2005	11
15	Molecular Classification of Multiple Myeloma (MM) Based on Gene Expression Profiling (GEP) and Fluorescence In Situ Hybridisation (FISH) Is an Independent Predictor for Event Free Survival (EFS). Blood ·Dirk Hose, Jean‐François Rossi, Carina Ittrich, John De Vos, Thierry Rème, Axel Benner, Karène Mahtouk, Coral del Val, Jérôme Moreaux, Agnes Hotz‐Wagenblatt, Musarat Abbas, Marc S. Raab, A L Matteson, Marion Moos, Aakansh Garg, Anna Jauch, Éric Jourdan, Friedrich W. Cremer, Bernard Klein, Hartmut Goldschmidt	2005	8
16	Zinc‐metallothionein genoprotective effect is independent of the glutathione depletion in HaCaT keratinocytes after solar light irradiation Journal of Cellular Biochemistry ·Éric Jourdan, Iván Rosero-Rodríguez, Régine Steiman, Pascale Guiraud	2004	16
17	Survival and Proliferation Factors of Normal and Malignant Plasma Cells International Journal of Hematology ·Bernard Klein, Karin Tarte, Michel Jourdan, Marie-Claude Codsi, Jérôme Moreaux, Éric Jourdan, Éric Legouffe, John De Vos, Drago Ružić	2003	175
18	Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation Leukemia ·Mohamad Mohty, Karin Bilger, Éric Jourdan, Mathieu Kuentz, Mauricette Michallet, Jean Henri Bourhis, Nöel Milpied, Laurent Sutton, J. P. Jouet, Michel Attal, Pierre Bordigoni, J Cahn, Alain Sadoun, Norbert Ifrah, Denis Guyotat, Catherine Faucher, Nathalie Fegueux, Josy Reiffers, D Maraninchi, Didier Blaise	2003	101
19	Outcome of Adult Patients with Acute Myeloid Leukemia who Failed to Achieve Complete Remission after one Course of Induction Chemotherapy: A Report from the BGMT Study Group: For the BGMT Leukemia & lymphoma ·Éric Jourdan, Josy Reiffers, Anne Marie Stoppa, J.J. Sotto, Michel Attal, María Moreno Salinas, Gérald Marit, Nathalie Fegueux, Olivier Boulat, Nicole Dastugue, J.-M. Boiron, C. Fabères, J.A. Gastaut, D Maraninchi, Didier Blaise	2001	10
20	A Randomized Prospective Multicentre Trial of Cefpirome Versus Piperacillin-Tazobactam in Febrile Neutropenia Leukemia & lymphoma ·Abdukerim Haji, Cordova Lovera, Olivier Boulat, Françoise Rigal‐Huguet, Lysiane Molina, Nathalie Fegueux, Éric Jourdan, Jean‐Michel Boiron, Josy Reiffers	2001	14

About Éric Jourdan

Éric Jourdan is a scholar working on Hematology, Genetics, Immunology and Allergy, Oncology and Pathology and Forensic Medicine, having authored 54 papers that have together received 2.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (21 papers), Multiple Myeloma Research and Treatments (17 papers), Chronic Myeloid Leukemia Treatments (13 papers), Chronic Lymphocytic Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (7 papers), Hematopoietic Stem Cell Transplantation (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). The work is most often cited by research in Hematology (1.3k citations), Genetics (407 citations), Immunology (568 citations), Oncology (570 citations) and Cancer Research (198 citations). Éric Jourdan has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Bernard Klein, Jérôme Moreaux, Éric Legouffe, Thierry Rème, Karin Tarte, John De Vos, Jean‐François Rossi, Philippe Quittet, Philippe Le Moine and Michel Jourdan. Their work appears in journals such as Blood, Haematologica, Journal of Clinical Oncology, British Journal of Haematology and Human Gene Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact